These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26953483)

  • 1. [Hepatitis C].
    Weiß J; Geier A
    MMW Fortschr Med; 2015 Nov; 157 Spec No 2():86-9; quiz 90. PubMed ID: 26953483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Direct-acting antiviral treatment of chronic hepatitis C infection].
    Grüner N; Gerbes A
    MMW Fortschr Med; 2015 Apr; 157(8):57-60. PubMed ID: 26012687
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis C: improved cure rates with new approved medications].
    Grammatikos G; Vermehren J; Zeuzem S
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():65-9; quiz 70. PubMed ID: 22916428
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of chronic hepatitis C].
    Schaffstein S; Rampini SK; Müllhaupt B
    Praxis (Bern 1994); 2014 Apr; 103(8):423-36. PubMed ID: 24713377
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies with boceprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C update: what has changed? What can we expect in the near future?].
    Geier A
    MMW Fortschr Med; 2013 Nov; 155(19):59-62. PubMed ID: 24475674
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs in development for chronic hepatitis C: a promising future.
    Pockros PJ
    Expert Opin Biol Ther; 2011 Dec; 11(12):1611-22. PubMed ID: 21995412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of hepatitis C: new inhibitors as hammers against HCV].
    Bublak R
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643
    [No Abstract]   [Full Text] [Related]  

  • 9. Are we nearing the end in the fight against hepatitis C?
    Chua JV; Kottilil S
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):499-500. PubMed ID: 28335650
    [No Abstract]   [Full Text] [Related]  

  • 10. Mexican consensus on the diagnosis and management of hepatitis C infection.
    Sánchez-Ávila JF; Dehesa-Violante M; Méndez-Sánchez N; Bosques-Padilla F; Castillo-Barradas M; Castro-Narro G; Cisneros-Garza L; Chirino-Sprung RA; García-Juarez I; Gonzalez-Huezo MS; Malé-Velazquez R; Moreno-Alcántar R; Muñoz-Espinoza L; Ramos-Gómez M; Rizo-Robles MT; Sandoval-Salas R; Sierra-Madero J; Torres-Ibarra Mdel R; Vazquez-Frias R; Wolpert-Barraza E; ; ;
    Ann Hepatol; 2015; 14 Suppl 1():5-48. PubMed ID: 25983318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Targeted against every genotype].
    Urban & Vogel
    MMW Fortschr Med; 2015 Apr; 157(6):34. PubMed ID: 26015198
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectious disease. Despite setbacks, optimism on drugs for hepatitis C.
    Cohen J
    Science; 2012 Sep; 337(6101):1450-1. PubMed ID: 22997303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of chronic hepatitis C: protease inhibitors significantly increase rate of healing].
    Stiefelhagen P; Einecke D
    MMW Fortschr Med; 2011 Jul; 153(29-31):14-5. PubMed ID: 21834169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic hepatitis C. Chances of healing good as never before].
    MMW Fortschr Med; 2003 Oct; 145(42):61. PubMed ID: 14655449
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
    Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
    Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
    [No Abstract]   [Full Text] [Related]  

  • 16. Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?
    Brochot E; Bodeau S; Duverlie G
    Ther Drug Monit; 2015 Aug; 37(4):550-1. PubMed ID: 25525764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies with telaprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):15. PubMed ID: 21830727
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype.
    Lee SW; Yang SS; Lee TY; Yeh HZ; Lu IT; Chang CS
    J Gastrointestin Liver Dis; 2017 Jun; 26(2):205-206. PubMed ID: 28617895
    [No Abstract]   [Full Text] [Related]  

  • 19. [Standard diagnostic and therapeutic approach to chronic hepatitis C virus (HCV) infection 22 - guidelines].
    Urbánek P; Husa P; Plíšek S; RoŽnovský L
    Klin Mikrobiol Infekc Lek; 2017 Mar; 23(1):22-40. PubMed ID: 28467593
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns.
    Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
    Hepatology; 2009 Jun; 49(6):2125; author reply 2125-6. PubMed ID: 19479790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.